Bone grafting is a surgical procedure that involves bone transplantation to fix damaged or fractured bones. In bone allografts, bone tissues are obtained from a donor. This graft can be used in surgical procedures to help promote bone growth and healing in the patient's body. The bone tissue is sterilized before and processed to remove any contaminates, at the same time maintaining the structural integrity of the tissue. This bone is usually obtained from the cadavers that have donated their bones to the bone bank. It can be used in a variety of procedures, including spinal fusions, joint replacements, and fracture repair. This is often used as an alternative to harvesting a patient's own bone tissue, which can be a more invasive procedure with longer recovery times.
There are several driving factors for the bone allograft market. The cases of osteoporosis, a condition where the bones become more susceptible to fractures, thus weakening the bone strength have been increasing owing to the changing lifestyle. According to National Institute on Aging, it is more common in females over the age of 50 than males. This can act as a driver for the market. Other than this, the prevalence of musculoskeletal disorders has risen in the last few years. Since they are one of the main causes of long-term pain and disability, treatment must be done as early as possible. The development of biocompatible allografts that are nontoxic to human tissue may also help to increase the market share for bone allografts. These synthetic allografts are prepared from biocompatible ceramics, glasses, polymers, and collagen. Lastly, the increase in demand for dental surgeries may also drive this market. These procedures add bones to the places or sockets where it is damaged.
Although the bone allograft market is anticipated to grow during the forecast period, several factors may restrict the growth of the market. The cost of surgical procedures can be high, particularly for more advanced systems. This could limit the inclination of people toward surgeries, especially those who cannot afford them. This market may also show hindrances in developing countries or areas with limited healthcare resources. Along with this, there are some ethical concerns relating to the grafting of bones. Since these procedures need the donation of bone tissues, informed consent must be obtained from the donor. They should be made aware of the risks associated with the donation of bone tissue. Some religions forbid such practices regarding it as a process of turning the body into a moneymaking tool. These ethical dilemmas and high costs may act as a challenge to the bone allograft market.
Advances in genomics and tissue engineering could enable the development of personalized bone grafts tailored to a patient's needs and biology. Increased focus of key market players on R&D activities in bone grafts and the development of their substitutes may also provide various lucrative opportunities for this market. In recent years, there has been a shift from autografts to allografts owing to several factors. Autografts are harvested from the patient's own body, whereas allografts are obtained from a donor. Autografts require an additional surgical site to harvest the tissue, which can lead to increased pain and longer recovery times for the patient. In contrast, allografts are readily available and do not require an additional surgical site. Due to this, allografts are available in various shapes and sizes, and surgeons can choose the most appropriate grafts for the patient's needs.
New product launches to flourish in the market.
In March 2022, Biocomposites, an international medical devices company signed a joint venture with Zimmer Biomet for the distribution of Genex Bone Graft Substitute exclusively. Genex bone substitute is a synthetic absorbable graft developed for promoting the regeneration of bones during various defects. It acts as a catalyst for bone healing by complementing the body's natural healing process. Genex is fully absorbed and reformed in a year, with no foreign objects left to risk structural integrity.
Segment Overview:
By type: The bone allograft market is divided into corticocancellous bone allografts, osteoinductive bone allografts, and massive structural bone allografts. The osteoinductive bone allografts segment held the largest market revenue in 2021 and is expected to do so in the forecast period. This can be attributed to various factors like osteoconductiveness and immediate structural support.
By application: The bone allograft market is classified as spinal fusion, trauma, craniomaxillofacial, joint reconstruction, and dental bone grafting. The spinal fusion segment accounted for the largest market share in 2021. The market share for joint reconstruction may show a steady growth during the forecast period owing to an increase in the geriatric population. According to WHO, the geriatric population is anticipated to double till 2050. The dental bone grafting market may also grow during the upcoming years due to an increase in the use of grafts for dental procedures and availability of bone grafts for dental applications.
By end-use: The bone allograft market is classified as hospitals & specialty clinics, ambulatory surgical centers, and others. The hospital segment accounted for the largest bone graft market share in 2021 and is predicted to dominate the market during the forecast period. This can be due to the availability of advanced medical technologies, highly skilled healthcare professionals, and a wide range of personalized services offered in the hospitals. Ambulatory surgical centers are also increasingly becoming popular for outpatient procedures.
By region: The bone allograft market is segmented as North America, Europe, Asia-Pacific, and LAMEA. The North America segment accounted for the highest market revenue owing to increased demand of grafts for trauma injuries. Also, due to increase in awareness and a well-developed healthcare structure, this segment may grow in the upcoming years. Asia-Pacific may also expand owing to the rise in prevalence of orthopedic disorders and increase in government initiatives for its treatment.
Competitive analysis and profiles of the major players in the bone allograft market, such as Arthrex Inc., Baxter International Inc., Integra Life Sciences Holdings Co., Johnson & Johnson (Depuy Synthes), Medtronic plc, Musculoskeletal Transplant Foundation, NuVasive Inc., Stryker Co., Xtant Medical Holdings Inc., and Zimmer Biomet Holdings, Inc. are provided in this report.
There are several driving factors for the bone allograft market. The cases of osteoporosis, a condition where the bones become more susceptible to fractures, thus weakening the bone strength have been increasing owing to the changing lifestyle. According to National Institute on Aging, it is more common in females over the age of 50 than males. This can act as a driver for the market. Other than this, the prevalence of musculoskeletal disorders has risen in the last few years. Since they are one of the main causes of long-term pain and disability, treatment must be done as early as possible. The development of biocompatible allografts that are nontoxic to human tissue may also help to increase the market share for bone allografts. These synthetic allografts are prepared from biocompatible ceramics, glasses, polymers, and collagen. Lastly, the increase in demand for dental surgeries may also drive this market. These procedures add bones to the places or sockets where it is damaged.
Although the bone allograft market is anticipated to grow during the forecast period, several factors may restrict the growth of the market. The cost of surgical procedures can be high, particularly for more advanced systems. This could limit the inclination of people toward surgeries, especially those who cannot afford them. This market may also show hindrances in developing countries or areas with limited healthcare resources. Along with this, there are some ethical concerns relating to the grafting of bones. Since these procedures need the donation of bone tissues, informed consent must be obtained from the donor. They should be made aware of the risks associated with the donation of bone tissue. Some religions forbid such practices regarding it as a process of turning the body into a moneymaking tool. These ethical dilemmas and high costs may act as a challenge to the bone allograft market.
Advances in genomics and tissue engineering could enable the development of personalized bone grafts tailored to a patient's needs and biology. Increased focus of key market players on R&D activities in bone grafts and the development of their substitutes may also provide various lucrative opportunities for this market. In recent years, there has been a shift from autografts to allografts owing to several factors. Autografts are harvested from the patient's own body, whereas allografts are obtained from a donor. Autografts require an additional surgical site to harvest the tissue, which can lead to increased pain and longer recovery times for the patient. In contrast, allografts are readily available and do not require an additional surgical site. Due to this, allografts are available in various shapes and sizes, and surgeons can choose the most appropriate grafts for the patient's needs.
New product launches to flourish in the market.
In March 2022, Biocomposites, an international medical devices company signed a joint venture with Zimmer Biomet for the distribution of Genex Bone Graft Substitute exclusively. Genex bone substitute is a synthetic absorbable graft developed for promoting the regeneration of bones during various defects. It acts as a catalyst for bone healing by complementing the body's natural healing process. Genex is fully absorbed and reformed in a year, with no foreign objects left to risk structural integrity.
Segment Overview:
By type: The bone allograft market is divided into corticocancellous bone allografts, osteoinductive bone allografts, and massive structural bone allografts. The osteoinductive bone allografts segment held the largest market revenue in 2021 and is expected to do so in the forecast period. This can be attributed to various factors like osteoconductiveness and immediate structural support.
By application: The bone allograft market is classified as spinal fusion, trauma, craniomaxillofacial, joint reconstruction, and dental bone grafting. The spinal fusion segment accounted for the largest market share in 2021. The market share for joint reconstruction may show a steady growth during the forecast period owing to an increase in the geriatric population. According to WHO, the geriatric population is anticipated to double till 2050. The dental bone grafting market may also grow during the upcoming years due to an increase in the use of grafts for dental procedures and availability of bone grafts for dental applications.
By end-use: The bone allograft market is classified as hospitals & specialty clinics, ambulatory surgical centers, and others. The hospital segment accounted for the largest bone graft market share in 2021 and is predicted to dominate the market during the forecast period. This can be due to the availability of advanced medical technologies, highly skilled healthcare professionals, and a wide range of personalized services offered in the hospitals. Ambulatory surgical centers are also increasingly becoming popular for outpatient procedures.
By region: The bone allograft market is segmented as North America, Europe, Asia-Pacific, and LAMEA. The North America segment accounted for the highest market revenue owing to increased demand of grafts for trauma injuries. Also, due to increase in awareness and a well-developed healthcare structure, this segment may grow in the upcoming years. Asia-Pacific may also expand owing to the rise in prevalence of orthopedic disorders and increase in government initiatives for its treatment.
Competitive analysis and profiles of the major players in the bone allograft market, such as Arthrex Inc., Baxter International Inc., Integra Life Sciences Holdings Co., Johnson & Johnson (Depuy Synthes), Medtronic plc, Musculoskeletal Transplant Foundation, NuVasive Inc., Stryker Co., Xtant Medical Holdings Inc., and Zimmer Biomet Holdings, Inc. are provided in this report.
Bone Allograft Market, by Type Report Highlights
| Aspects | Details |
 By Type |
|
 By Application |
|
 By End-use |
|
 By Region |
|
 Key Market Players | Arthrex Inc., NuVasive Inc., Stryker Corporation, Integra Life Sciences Holdings Corporation, Johnson & Johnson (Depuy Synthes), Musculoskeletal Transplant Foundation, Zimmer Biomet Holdings, Inc., Baxter International Inc., Xtant Medical Holdings Inc., Medtronic plc |
Loading Table Of Content...
